Blanket Purchase Agreement HT001421A0031
- Not listed
- The Department of Veterans Affairs (VA), Veterans Integrated Service Network (VISN) 22 awarded a single-award Blanket Purchase Agreement (BPA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype genetic testing services. The BPA has a ceiling value of $970,352 and a period of performance from February 2023 through February 2028. Under this IDV, the VA can order cancer screening, treatment selection, and disease monitoring testing services on an as-needed basis at...
- The federal contract IDV award is for Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX cancer testing services to the U.S. Air Force's Air Combat Command. The single-award indefinite delivery contract is valued at $996,710 and has a period of performance from March 2021 through March 2026, allowing the Air Force to order the proprietary cancer tests on an as-needed basis. Under this IDV, Genomic Health has received multiple firm fixed price delivery orders...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a single award blanket purchase agreement to Exact Sciences Corporation for Oncotype DX laboratory testing services. The BPA was awarded on a sole source basis utilizing Exact's Federal Supply Schedule contract for medical laboratory testing and analysis services. The potential value of the BPA is $690,792 for a base period running from March 13, 2024 through March 12, 2029. A firm...
- Exact Sciences Corporation, operating through its subsidiary Exact Sciences Laboratories, LLC, has been awarded a Blanket Purchase Agreement against the Medical Laboratory Testing and Analysis Services Federal Supply Schedule by the Defense Health Agency. The BPA establishes a single award agreement for Exact Sciences to provide cancer testing referral laboratory services to support healthcare programs through August 2026. The potential value is $463,098. Four calls have been placed against this...
- This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to Exact Sciences Corporation, specifically its Exact Sciences Laboratories, LLC division, for the provision of Oncotype DX cancer testing services. The BPA has a ceiling value of $900,925.40 and a period of performance from March 16, 2025 to March 15, 2026. Exact Sciences, which is the developer and manufacturer of the Cologuard colorectal...
- This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Veterans Health Administration (VHA) to Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division. The BPA has a total ceiling value of $335,800 and is for the provision of Oncotype DX cancer testing services, including gene expression profiling and genomic testing, to support federal healthcare programs. The contract utilizes Exact Sciences' Federal Supply...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) to Exact Sciences Corporation, a for-profit medical technology company. The contract, valued at $919,774.30, is for the provision of Genomic Health genetic testing services, primarily the Oncotype DX gene expression profiling test, to VISN 19 healthcare facilities. The contract utilizes the Medical Laboratory Testing and Analysis Services (FSS-621-II)...
- This Blanket Purchase Agreement (BPA) is a single-award federal contract vehicle administered by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to procure cancer diagnostic testing services from MdxHealth, Inc., a for-profit healthcare company. The BPA calls for MdxHealth to provide its MDXHEALTH GPS molecular diagnostic services, which utilize genetic and epigenetic biomarkers to support personalized diagnosis and treatment for various cancers...
- This federal Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and genomic testing solutions. The single-award BPA has a ceiling value of $7,433,000 and a period of performance through October 2028. Under this BPA, Qiagen will provide a range of reagents, consumables, laboratory equipment, and bioinformatics software to support DHA's...
- This Blanket Purchase Agreement (BPA), awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Hologic Sales And Service, LLC, a division of Hologic, Inc., facilitates the delivery of medical devices, diagnostic equipment, assays, reagents, and other supplies to support DHA's healthcare operations. The BPA, valued at up to $20,000,000, has a period of performance from August 2020 through August 2025. Under this IDV, Hologic will provide a range of...
- HT001421A0031Blanket Purchase Agreement
- 2Federal Contract Awards
The Defense Health Agency awarded a single-award blanket purchase agreement to Genomic Health, Inc., a division of Exact Sciences Corporation, for diagnostic services for oncology prostate testing. The potential value of the agreement is $5,000,000 to be utilized over four years through individual task order calls. The agreement aims to support the Agency's efforts to advance cancer screening and personalized treatment selection through Genomic Health's Oncotype Portfolio of genomic tests for earlier cancer detection and cancer treatment. A task order call against the blanket purchase agreement was awarded to Genomic Health, Inc. for $145,066.32 to deliver the Oncotype Portfolio genomic tests. Performance will take place in Bethesda, Maryland over one year under a firm fixed price arrangement. The task order aims to advance cancer screening and personalized treatment selection at the Defense Health Agency through Genomic Health's genomic tests for earlier cancer detection and cancer treatment selection. No subcontractors or socioeconomic set-asides were identified for this task order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 8/22/23 | |
| Not listed | Not listed | $0 | 9/28/21 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call HT001421A0031-HT001423F0136 | Genomic Health, Inc. | $145.1k | 9/8/23 | 9/7/24 | 8/31/23 | |
BPA Call HT001421A0031-HT001424F0122 | Genomic Health, Inc. | $145.1k | 9/8/24 | 9/7/25 | 8/19/24 |